medline.ch Onkologie Urologische Tumoren

	Does Tumor Grade Have any Prognostic Significance in Chromophobe Renal Cell Carcinoma: A Clinicopathological Study. J Cancer Allied Spec Sadaf S, Mushtaq S, Syed M, Hassan U, Hussain M, Loya A, Hameed M, Sheikh UN. PMID: 41841143 [PubMed]
	A Survey of Oncologists' Perceptions and Opinions Regarding Brain Imaging in Metastatic Renal Cell Carcinoma Within the UK. Cureus Crosby BT, Eloebhose E, Saeed MA, Sethi M, Winsor S, Spurr A, Tapia J, Ince W, Frazer R, McGrane J. PMID: 41841059 [PubMed]
	Immune-mediated pathways between red blood cell traits and prostate cancer: a causal relationship network based on Mendelian randomization evaluation. Aging Male Yang T, Zhang J, Li J, Yan Q, Li J. PMID: 41839839 [PubMed - indexed for MEDLINE]
	Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis. BJU Int Roessler N, Miszczyk M, Gontero P, Dematteis A, Miyajima K, Inoue S, Oberneder K, von Deimling M, Schuettfort VM, Vetterlein MW, Szabados B, Rajwa P, Karakiewicz PI, Teoh JY, Fisch M, Shariat SF. PMID: 41839747 [PubMed - as supplied by publisher]
	ASO Visual Abstract: A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Cancer Patients (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory. Ann Surg Oncol Wei W, Guo F, Zhang T, Chen Y, Li G, Luo J, Wan C. PMID: 41838357 [PubMed - as supplied by publisher]
	The dual role of pyroptosis in prostate cancer: new perspectives from molecular mechanisms to clinical translation. Mol Biol Rep Li W. PMID: 41838288 [PubMed - in process]
	Multi-institutional evaluation of prostate specific antigen dynamics after simple prostatectomy. World J Urol Livingston AJ, Segal D, Attia S, Dvergsten T, Gahan JC, Morgan TN. PMID: 41838166 [PubMed - indexed for MEDLINE]
	Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms. Mediators Inflamm Wang Y, Song Y, Ji H, Zhu B, Xie H. PMID: 41837832 [PubMed - indexed for MEDLINE]
	PRAD-Hybrid CNN (PRADHC): A Deep Learning Model for Assisted Diagnosis of Prostate Cancer on MRI. Curr Med Imaging Liu J, Hou L, Xu Y, Zhang Y, Zong H. PMID: 41837512 [PubMed - as supplied by publisher]
	Urinary Epithelial Cell Adhesion Molecule (EpCAM) as a Noninvasive Biomarker for Detecting Clinically Significant Prostate Cancer in Men With Equivocal PSA Levels. Biomed Res Int Opoku Mensah B, Fondjo LA, Nsiah P, Edwards E. PMID: 41837413 [PubMed - indexed for MEDLINE]
	Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for Muscle-Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials. Int J Urol Goto Y. PMID: 41837348 [PubMed - in process]
	Methylation and Expression Analysis of POU4F2, HOXA9, RBM46, and TSGA10 Genes in Bladder Cancer Using Methyl-Sensitive Restriction Enzyme PCR (MSRE-PCR). Cancer Manag Res Mahdipour S, Modarressi MH, Noruzinia M. PMID: 41836594 [PubMed]
	Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review. Cancer Manag Res Lu X, Bian X, Wang S, Ye D. PMID: 41836592 [PubMed]
	New-onset renal impairment following radical nephrectomy for renal cell carcinoma: a retrospective cohort study of clinical, intraoperative, and postoperative risk factors. Ther Adv Urol Seyam RM, Abduldaem AM, Alfehaid ON, Almaslamani AM, Alghsham FS, Alassaf NM, Alghanam NM, Sayed AG, Elnegali AI, Norris AM, Alzahrani HM. PMID: 41836458 [PubMed]
	Study on the mechanism of 18Î²-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis. Front Oncol Jia S, Zhang L, Li Y, Xu D, Yang Y, Zhou Z, Liu W, Zhao J, Yuan L, Nan Y. PMID: 41836244 [PubMed]
	A systematic characterization of amino acid metabolism-related genes reveals molecular subtypes and a prognostic signature in bladder cancer. Front Oncol He J, Liu X, Li S, Xia Z, Tan X, Peng L, Long Q, Wu J. PMID: 41836241 [PubMed]
	Defining recurrent urinary tract infections and quantifying bladder cancer risk in primary care in England: a nationwide case-control study. Lancet Prim Care Mahati SG, Wu J, Walter FM, Zhou Y. PMID: 41836076 [PubMed]
	Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies. Front Pharmacol Zhang M, Zhang Y, Shen F, Yan M, Cheng P, Teng J, Zou M, Yao W, Wang Z, Li W. PMID: 41836013 [PubMed]
	Dosimetric Impact of Artificial Intelligence (AI)-Based Autocontouring Software, OncoStudio, in High-Risk Prostate Cancer Treatment Planning: A Three-Group Comparative Study on the Slice Ranges of Seminal Vesicles. Cureus Kawaguchi M, Hoshina M, Sugahara S, Fujioka K, Takanashi M, Noguchi M, Oosato A, Masuda K, Katada Y, Saito K. PMID: 41835785 [PubMed]
	Harnessing Artificial Intelligence to Code a Decision-Making Aid for the Prostate Cancer Brachytherapy Multidisciplinary Meeting Using Retrieval-Augmented Generation. Cureus Gabriel A, Antonoglou G, Langley S, Gabriel J. PMID: 41835737 [PubMed]

Artikel 1 - 20 / 176866

Seite 1 von 8844

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung